Replies to post #15932 on Algernon Pharmaceuticals Inc (AGNPF)

[tcm55]

very confusing post.?.


MMND and CMPS are both doing Trials for the mental health uses of psychedelics. CMPS's recent trial was single large dose. I personally wouldn't support that level of a 'high' for anyone and like another company's MOU much better.
They both had larger MCs but are still about $300-400M now. Both have $0 revs.

AGN has followed the different path of the neuroplasticity effects of micro dosed DMT.
Seems a Big difference in the MOUs / applications of psychedelics with different patient groups.
Dr Nutt has significant insights for Both, IMO.

An occasional small dose of Shrooms DOES mitigate some of the side effects of chemo and mental stress, IMO. True hallucinogenic experiences should be left to the young and dumb, IMO...GLTA...